Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS

Celeste M. Karch, Mercedes Prudencio, Duane D. Winkler, P. John Hart, David R. Borchelt

Research output: Contribution to journalArticle

130 Citations (Scopus)

Abstract

Transgenic mice that model familial (f)ALS, caused by mutations in superoxide dismutase (SOD)1, develop paralysis with pathology that includes the accumulation of aggregated forms of the mutant protein. Using a highly sensitive detergent extraction assay, we traced the appearance and abundance of detergent-insoluble and disulfide cross-linked aggregates of SOD1 throughout the disease course of SOD1-fALS mice (G93A, G37R, and H46R/H48Q). We demonstrate that the accumulation of disulfide cross-linked, detergent-insoluble, aggregates of mutant SOD1 occurs primarily in the later stages of the disease, concurrent with the appearance of rapidly progressing symptoms. We find no evidence for a model in which aberrant intermolecular disulfide bonding has an important role in promoting the aggregation of mutant SOD1, instead, such cross-linking appears to be a secondary event. Also, using both cell culture and mouse models, we find that mutant protein lacking the normal intramolecular disulfide bond is a major component of the insoluble SOD1 aggregates. Overall, our findings suggest a model in which soluble forms of mutant SOD1 initiate disease with larger aggregates implicated only in rapidly progressing events in the final stages of disease. Within the final stages of disease, abnormalities in the oxidation of a normal intramolecular disulfide bond in mutant SOD1 facilitate the aggregation of mutant protein.

Original languageEnglish (US)
Pages (from-to)7774-7779
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume106
Issue number19
DOIs
StatePublished - May 12 2009

Fingerprint

Disulfides
Mutant Proteins
Detergents
Paralysis
Transgenic Mice
Cell Culture Techniques
Pathology
Mutation

Keywords

  • Neurodegenerative disease
  • Protein misfolding

ASJC Scopus subject areas

  • General

Cite this

Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. / Karch, Celeste M.; Prudencio, Mercedes; Winkler, Duane D.; Hart, P. John; Borchelt, David R.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 19, 12.05.2009, p. 7774-7779.

Research output: Contribution to journalArticle

Karch, Celeste M. ; Prudencio, Mercedes ; Winkler, Duane D. ; Hart, P. John ; Borchelt, David R. / Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. In: Proceedings of the National Academy of Sciences of the United States of America. 2009 ; Vol. 106, No. 19. pp. 7774-7779.
@article{c974790ad61b44b283ba5e3a43c77aab,
title = "Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS",
abstract = "Transgenic mice that model familial (f)ALS, caused by mutations in superoxide dismutase (SOD)1, develop paralysis with pathology that includes the accumulation of aggregated forms of the mutant protein. Using a highly sensitive detergent extraction assay, we traced the appearance and abundance of detergent-insoluble and disulfide cross-linked aggregates of SOD1 throughout the disease course of SOD1-fALS mice (G93A, G37R, and H46R/H48Q). We demonstrate that the accumulation of disulfide cross-linked, detergent-insoluble, aggregates of mutant SOD1 occurs primarily in the later stages of the disease, concurrent with the appearance of rapidly progressing symptoms. We find no evidence for a model in which aberrant intermolecular disulfide bonding has an important role in promoting the aggregation of mutant SOD1, instead, such cross-linking appears to be a secondary event. Also, using both cell culture and mouse models, we find that mutant protein lacking the normal intramolecular disulfide bond is a major component of the insoluble SOD1 aggregates. Overall, our findings suggest a model in which soluble forms of mutant SOD1 initiate disease with larger aggregates implicated only in rapidly progressing events in the final stages of disease. Within the final stages of disease, abnormalities in the oxidation of a normal intramolecular disulfide bond in mutant SOD1 facilitate the aggregation of mutant protein.",
keywords = "Neurodegenerative disease, Protein misfolding",
author = "Karch, {Celeste M.} and Mercedes Prudencio and Winkler, {Duane D.} and Hart, {P. John} and Borchelt, {David R.}",
year = "2009",
month = "5",
day = "12",
doi = "10.1073/pnas.0902505106",
language = "English (US)",
volume = "106",
pages = "7774--7779",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "19",

}

TY - JOUR

T1 - Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS

AU - Karch, Celeste M.

AU - Prudencio, Mercedes

AU - Winkler, Duane D.

AU - Hart, P. John

AU - Borchelt, David R.

PY - 2009/5/12

Y1 - 2009/5/12

N2 - Transgenic mice that model familial (f)ALS, caused by mutations in superoxide dismutase (SOD)1, develop paralysis with pathology that includes the accumulation of aggregated forms of the mutant protein. Using a highly sensitive detergent extraction assay, we traced the appearance and abundance of detergent-insoluble and disulfide cross-linked aggregates of SOD1 throughout the disease course of SOD1-fALS mice (G93A, G37R, and H46R/H48Q). We demonstrate that the accumulation of disulfide cross-linked, detergent-insoluble, aggregates of mutant SOD1 occurs primarily in the later stages of the disease, concurrent with the appearance of rapidly progressing symptoms. We find no evidence for a model in which aberrant intermolecular disulfide bonding has an important role in promoting the aggregation of mutant SOD1, instead, such cross-linking appears to be a secondary event. Also, using both cell culture and mouse models, we find that mutant protein lacking the normal intramolecular disulfide bond is a major component of the insoluble SOD1 aggregates. Overall, our findings suggest a model in which soluble forms of mutant SOD1 initiate disease with larger aggregates implicated only in rapidly progressing events in the final stages of disease. Within the final stages of disease, abnormalities in the oxidation of a normal intramolecular disulfide bond in mutant SOD1 facilitate the aggregation of mutant protein.

AB - Transgenic mice that model familial (f)ALS, caused by mutations in superoxide dismutase (SOD)1, develop paralysis with pathology that includes the accumulation of aggregated forms of the mutant protein. Using a highly sensitive detergent extraction assay, we traced the appearance and abundance of detergent-insoluble and disulfide cross-linked aggregates of SOD1 throughout the disease course of SOD1-fALS mice (G93A, G37R, and H46R/H48Q). We demonstrate that the accumulation of disulfide cross-linked, detergent-insoluble, aggregates of mutant SOD1 occurs primarily in the later stages of the disease, concurrent with the appearance of rapidly progressing symptoms. We find no evidence for a model in which aberrant intermolecular disulfide bonding has an important role in promoting the aggregation of mutant SOD1, instead, such cross-linking appears to be a secondary event. Also, using both cell culture and mouse models, we find that mutant protein lacking the normal intramolecular disulfide bond is a major component of the insoluble SOD1 aggregates. Overall, our findings suggest a model in which soluble forms of mutant SOD1 initiate disease with larger aggregates implicated only in rapidly progressing events in the final stages of disease. Within the final stages of disease, abnormalities in the oxidation of a normal intramolecular disulfide bond in mutant SOD1 facilitate the aggregation of mutant protein.

KW - Neurodegenerative disease

KW - Protein misfolding

UR - http://www.scopus.com/inward/record.url?scp=66049156169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66049156169&partnerID=8YFLogxK

U2 - 10.1073/pnas.0902505106

DO - 10.1073/pnas.0902505106

M3 - Article

VL - 106

SP - 7774

EP - 7779

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 19

ER -